Cellares Stock

www.cellares.com/Healthcare / Healthcare providers & servicesFounded: 2019Funding to Date: $355.75MM

Cellares, founded in 2019, is a cell therapy manufacturer that strives to develop scalable solutions to accelerate care for people living with a range of diseases. The company is the first Integrated Development and Manufacturing Organization (IDMO), and its Cell Shuttle platform aims to use automation to increase productivity at facilities that manufacture cell therapies for both autologous and allogeneic processes. Cellares is headquartered in San Francisco, California.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Cellares, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Cellares’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cellares.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Fabian Gerlinghaus
Co-Founder & Chief Executive Officer
Omar Kurdi
Co-Founder & President
Gary Lo
Chief Financial Officer

Board Members

Justin Butler
Eclipse Ventures
Victor Tong Jr.
Decheng Capital

Cellares’ stock FAQs

plusminus

Can you buy Cellares’ stock?

As Cellares is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Cellares, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Cellares’ stock?

To invest in a private company like Cellares’ through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Cellares’ stock?

Yes, you may be able to sell your Cellares’ stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Cellares’ stock?

If you hold private company shares of Cellares’ - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Cellares’ on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Cellares’ a public company?

No, Cellares’ is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Cellares’ stock price?

Cellares is a privately held company and therefore does not have a public stock price. However, you may access Cellares’ private market stock price with Forge Data.
plusminus

What is Cellares’ stock ticker symbol?

Cellares does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Cellares unveils $255M investment round with Bristol Myers among those in the fold

Wednesday, Cellares revealed a $255 million series C investment round to complete construction of its commercial-scale cell therapy manufacturing facility in Bridgewater, New Jersey. The fresh funding follows an $82 million series B round in 2021 and brings total backing in the company to $355 million.
Updated on: Jul 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.